Skip to main content
SINT logo

SINT · Sintx Technologies, Inc.

$1.51 -0.05 (-3.21%) At close · Jul 29
Market Cap
$6.52M
Shares
4.32M

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$1.02M -64.7%
FY2025 Revenue FY2013–FY2025
Net Income
-$10.36M +6%
FY2025 Net Income FY2013–FY2025
Gross Margin
45.28% -26.6pp
FY2025 Gross Margin FY2013–FY2025
Operating Margin
-1053.14% -566.6pp
FY2025 Operating Margin FY2013–FY2025
Diluted EPS
-$6.16 +59.4%
FY2025 Diluted EPS FY2018–FY2025
Operating Cash Flow
-$8.57M +0.8%
FY2025 Operating Cash Flow FY2013–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013
$1.03M $1.02M $2.89M $2.63M $1.56M $606K $594K $689K $95K $11.23M $15.23M $19.45M $22.77M $22.31M
$547K $557K $811K $784K $265K $449K $475K $551K $56K $6.35M $3.78M $6.25M $7.91M $7.05M
$482K $461K $2.08M $1.84M $1.3M $157K $119K $138K $39K $4.88M $11.45M $13.2M $14.86M $15.27M
45.28% 71.91% 70.16% 83.02% 25.91% 20.03% 20.03% 41.05% 43.43% 75.19% 67.87% 65.25% 68.43%
$3.84M $4.59M $5.2M $8.71M $6.45M $5.89M $4.81M $3.39M $2.99M $3.51M $6.35M $6.39M $6.74M $3.46M
$621K $242K $614K $1.14M $1.34M $1.29M $683K $430K $135K $325K $10.35M $12.42M $18.69M $16.38M
$7.41M $6.2M $4M $4.22M $3.99M $3.6M $3.13M $2.91M $3.87M $3.65M $6.29M $6.44M $13.59M $5.76M
$19K $5000 $5000 $5000 $5000 $5000 $5000 $4000 $536K $501K $501K $501K $501K
$12.03M $11.18M $16.12M $15.2M $12.63M $10.78M $8.62M $6.73M $13.16M $7.49M $22.98M $25.24M $39.02M $25.6M
-$11.55M -$10.72M -$14.05M -$13.36M -$11.34M -$10.62M -$8.5M -$6.59M -$13.12M -$7.49M -$11.54M -$12.04M -$24.17M -$10.34M
-1053.14% -486.56% -508.49% -726.14% -1752.48% -1431.65% -957.04% -13806.32% -66.67% -75.76% -61.9% -106.16% -46.32%
$4.84M $3.65M $1.85M
$1000 $12K $16K
$652K $357K $3.02M $5.1M -$704K $1.31M $1.48M $1.8M $3.43M $1.72M -$3.23M -$11.87M -$8.42M $2.05M
-$10.89M -$10.36M -$11.02M -$8.26M -$12.04M -$9.31M -$7.03M -$4.8M -$9.69M -$5.76M -$14.76M -$23.91M -$32.58M -$8.29M
-$10.89M -$10.36M -$11.02M -$8.26M -$12.04M -$9.31M -$7.03M -$4.8M -$8.65M -$9.33M -$14.76M -$23.91M -$32.58M -$8.29M
-1018.07% -381.85% -314.39% -771.24% -1536.14% -1183.33% -696.23% -9107.37% -83.09% -96.96% -122.92% -143.12% -37.13%
-$17.08M -$11.02M -$8.29M -$16.49M -$9.31M -$16.59M -$7.5M -$22.55M -$9329 -$21.04M -$23.91M
-$1.13M -$14.76M -$23.91M -$32.58M -$8.29M
USD/shares -$6.16 -$14.87 -$443.47 -$10,934.00 -$7,540.00 -$20,200.00 -$96,400.00 -$1,237,000.00 -$62,600.00
USD/shares -$6.16 -$15.19 -$624.47 -$12,162.00 -$7,982.00 -$21,600.00 -$113,800.00 -$1,534,600.00
shares 2.77M 741.25K 18.68K 1508.05 1234.595 820.3278 77.7994 18.2301 148.9452 77.1868 18.1011 40.7999 26.7037
shares 2.77M 744.78K 21.79K 1586.615 1253.505 872.3074 77.7994 19.1928 148.9452 77.1868 18.1011 40.7999 26.7037
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2015–FY2025: $253K in buybacks.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
Peer median 0.58×
EV/EBIT
P/E (TTM)
Peer median 4.14×

Peer medians compare against the 55 similar-size Medical Devices companies (of 145 listed).

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Product & Service (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021
Product $729,000 $1,246,000 $1,226,000 $601,000 $606,000
Grant and Contract $289,000 $1,641,000 $1,401,000 $960,000
Key facts CIK 1269026 CUSIP 829392703 13F (30d) 5 filings 5 filers Visit website Investor relations